Australia, Oct. 14 -- Anthia Life Sciences Pty. Ltd., owns the trademark (2632075) for 'Ocogen' till March 3, 2036.
Status: registered:
Registered/protected
Classes: 5 [drugs for medical use; drugs for medical purposes; medicine; medicines for human purposes; pharmaceutical products for use by humans; pharmaceuticals; pharmaceutical drugs; pharmaceutical pills; hormones for medical use; hormones for medical purposes; therapeutic drugs and agents; pharmaceutical preparations containing hormones for humans; medicines; medicines for adjusting the menstrual cycle; pharmaceutical preparations; pharmaceutical and medical preparations; pharmaceutical preparations and substances; pharmaceutical preparations being hormone preparations for human use; A synthetic hormone for the treatment of infertility] and 44 [healthcare; providing medical treatment; provision of medical treatment; medical treatment services provided by clinics and hospitals; providing healthcare services; prescription of medicines; medical, medicinal and pharmaceutical consultancy; medical services; medical clinic services; medical treatment services; human fertility treatment services; treatment of infertility; provision of medical information; medicine information services; provision of health care information by telephone and the Internet; providing health information via a website; health counseling; provision of healthcare services; consultancy relating to healthcare; consultancy services relating to healthcare]
Type of Mark: Word
Date of Acceptance: May 6
Registration Advertised: Oct. 13
For further details contact Argyll Law.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2632075.
Disclaimer: Curated by HT Syndication.
